- Pharmacodynamics of Aspirin Through Gestation: Predictors of Aspirin Response and Association With Pregnancy Outcome, a Prospective Cohort Study
- Phosphatidylserine-blocking nanoparticles inhibit thrombosis without increased bleeding in mice
- Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments
- Aspirin pharmacokinetics and pharmacodynamics through gestation
- A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity
Steven E. McKenzie, MD, PhD
Professor of Medicine
Cardeza Foundation for Hematologic Research
Contact Information
1020 Locust Street
Suite 394
Philadelphia, PA 19107
215-955-8544
215-955-9170 fax
Professor of Medicine
Cardeza Foundation for Hematologic Research
Publications
Research & Clinical Interests
Dr. McKenzie directs two major research projects. The first project involves vascular biology, with a focus on immune-mediated thrombocytopenia and thrombosis syndromes. This work, done in collaboration with Dr. Michael Reilly, led to the first model of heparin-induced thrombocytopenia and thrombosis. New work on effects of elevated cholesterol and athrosclerosis on HITT, and on microparticles and tissue factor, is ongoing.